CLINICAL_TRIALS
trial_result
· 2023-10-17
Clinical Trial Update: A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps [Phase 2]
Summary
A Phase 2 trial investigating CBP-201 (Rademikibart) in adults with chronic rhinosinusitis with nasal polyps was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Connect Biopharm LLC | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | Status: TERMINATED | Results posted: 2023-10-17